CI
GILD icon

Cavalier Investments’s Gilead Sciences GILD Stock Holding History

Cavalier Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-22,000
Closed -$1.65M – 91
2020
Q1 		$1.65M Buy
+22,000
New +$1.52M 0.97% 29
2017
Q1 		– Sell
-2,838
Closed -$203K – 158
2016
Q4 		$203K Buy
2,838
+88
+3% +$6.54K 0.13% 115
2016
Q3 		$218K Buy
+2,750
New +$223K 0.13% 114
2016
Q2 		– Sell
-13,100
Closed -$1.2M – 127
2016
Q1 		$1.2M Sell
13,100
-2,951
-18% -$266K 0.69% 29
2015
Q4 		$1.63M Buy
16,051
+2,951
+23% +$307K 0.97% 18
2015
Q3 		$1.29M Buy
+13,100
New +$1.45M 1.08% 21

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Cavalier Investments's GILD Position: Q2 2020 in Review

Cavalier Investments sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 22,000 shares — an estimated $1.65M sold.

Cavalier Investments first reported a position in GILD in Q3 2015 and held it in 6 quarters. The position peaked at $1.65M in Q1 2020. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Cavalier Investments reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • Cavalier Investments sold 22,000 Gilead Sciences shares in Q2 2020, an estimated $1.65M.
  • Cavalier Investments first reported a position in Gilead Sciences in Q3 2015 and held it in 6 quarters.
  • Cavalier Investments's Gilead Sciences position peaked at $1.65M in Q1 2020.
  • 1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Cavalier Investments's 13F filing for Q2 2020, filed 10 Aug 2020.